NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
批准号:
7522733
负责人:
Thomas P. Zwaka
金额:
$30.7万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-01 至 2013-05-31
关键词:
AddressAffectApoptosisApoptoticCaspaseCell DeathCell Differentiation processCellsCleaved cellClinicalDevelopmentDevelopmental BiologyDiseaseEmbryoEnzymesGoalsHuman bodyIn VitroKnock-outLinkMeasuresMediatingMediator of activation proteinMolecularPathway interactionsPhenotypePluripotent Stem CellsProcessProteinsPublic HealthRegenerative MedicineRegulationResistanceRoleSignal TransductionSmall Interfering RNASystemTestingThinkingUndifferentiatedWorkcaspase-3caspase-9cell typedrug discoveryembryonic stem cellgenetic regulatory proteininsightloss of functionmutantpluripotencyresearch studyself-renewalsmall hairpin RNAstemstem cell fatetooltranscription factortransplantation medicine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Embryonic stem (ES) cells are pluripotent and can expand in vitro without any apparent limits, while retaining their ability to become any type of cell in the body. The long-term goal of this proposal is to link the molecular mechanisms of programmed cell death to those underlying ES cell renewal and differentiation, with a view toward accelerating the clinical introduction of ES cell regenerative medicine. In my preliminary studies, I found that caspase-3, an important mediator of programmed cell death, has an unexpected role in controlling ES cell fate. I demonstrate an increase of caspase-3 activity upon induction of differentiation and show that caspase-3 can directly cleave the Nanog transcription factor, leading to rapid loss of this core pluripotency- related protein and subsequent ES cell differentiation it typically mediates. These results suggest that caspase- 3 and perhaps other key components of the programmed cell death pathway may have an integral role in the regulation of ES cell renewal/differentiation. The central hypothesis of this proposed work is that classical mediators of programmed cell death, especially caspase-3, also mediate the fate decisions affecting pluripotent stem cells. In Aim 1 I will dissect the functional roles of caspase-3 and it's activating caspase in the fate of ES cells. In Aim 2 I will modulate caspase activity in ES cells and assess the effects on self-renewal, differentiation and programmed cell death. I will also address the question of whether the differentiation-promoting activity of caspase-3 in ES cells is due to an instructive or selective signaling and elucidate if caspase activity provides a specific signal to differentiate or simply promotes differentiation in general. In Aim 3 I will assess the importance of caspase-3-mediated cleavage of Nanog in ES cell differentiation. I consider the transcription factor Nanog to be a paradigm for other potential caspase targets in ES cells, so that my findings for this regulatory protein could well extend to other transcriptional pathways involved in ES cell differentiation. Results of the experiments described in this proposal are expected to provide insight into the pleiotropic effects of caspases in pluripotent stem cells. Thus, specific pharmacological alteration of caspases may be useful not only for modulating apoptosis, but also for directing stem cell fate. The involvement of caspases in nonapoptotic pathways suggests that efforts to block apoptosis via caspase inhibition could have much broader consequences than initially thought.
Public Health Relevance: The ability of embryonic stem cells to remain undifferentiated in culture while retaining the ability to become any cell within the human body make them an invaluable tool for use in transplant medicine, drug discovery, and understanding basic developmental biology. Results of the experiments described in this proposal are expected to provide insight into the pleiotropic effects of the cell death enzyme caspase on the differentiation process of embryonic stem cells. Specific pharmacological alteration of caspases may be useful not only for modulating programmed cell death, but also for directing stem cell fate.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bat pluripotent stem cells as a novel experimental system
-
批准号:10592777
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2023
-
负责人:Thomas P. Zwaka
-
依托单位:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
-
批准号:10356153
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2020
-
负责人:Thomas P. Zwaka
-
依托单位:
Protection of early embryogenesis and pluripotent stem cells against genetic parasites through a primitive immune system
-
批准号:10570214
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2020
-
负责人:Thomas P. Zwaka
-
依托单位:
An inquiry into the function of Ronin in embryogenesis and pluripotent stem cells
-
批准号:9897561
-
项目类别:
-
资助金额:$46.61万
-
财政年份:2018
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:7826576
-
项目类别:
-
资助金额:$30.39万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:8269736
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:7655456
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
NON-APOPTOTIC ACTION OF CASPASES IN PLURIPOTENT EMBRYONIC STEM CELLS
-
批准号:8073463
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2008
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7356524
-
项目类别:
-
资助金额:$22.75万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7678452
-
项目类别:
-
资助金额:$22.67万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
Thanatos-Associated Protein 11 (Thap11) in Human Embryonic Stem Cells
-
批准号:7915185
-
项目类别:
-
资助金额:$23.23万
-
财政年份:--
-
负责人:Thomas P. Zwaka
-
依托单位:
海外基金